FIFTH AMENDMENT TO LEASECatalyst Pharmaceuticals, Inc. • May 13th, 2020 • Pharmaceutical preparations
This Fifth Amendment to Lease (this “Fifth Amendment”) is made and entered into by and between PRII 355 ALHAMBRA CIRCLE, LLC, a Delaware limited liability company (“Landlord”), as successor-in-interest to 355 Alhambra Plaza, Ltd., a Florida limited partnership (“Original Landlord”) and to CPT 355 Alhambra Circle, LLC, a Delaware limited liability company (“Intermediate Landlord”), and CATALYST PHARMACEUTICALS, INC. (f/k/a Catalyst Pharmaceutical Partners, Inc.), a Delaware corporation (“Tenant”), effective as of the date this Fifth Amendment is executed by Landlord, as evidenced on the signature page attached hereto (the “Effective Date”).
